HealthcareServices

Neurological Disorder Diagnostics Industry Poised for Rapid Growth, Forecast to Touch $17.74 Billion by 2030 at 7% CAGR

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the neurological disorder diagnostics market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Neurological Disorder Diagnostics Market between 2026 and 2030?_x000D_

The neurological disorder diagnostics market size has experienced strong growth in recent years. It is projected to expand from $12.61 billion in 2025 to $13.54 billion in 2026, at a compound annual growth rate (CAGR) of 7.3%. This historic growth can be linked to factors such as the increasing prevalence of neurological disorders, rising awareness about the importance of early diagnosis, the expansion of advanced imaging infrastructure, growing research funding for neurology, and improved availability of diagnostic instruments._x000D_

_x000D_

The neurological disorder diagnostics market size is projected for substantial growth over the next few years, expected to reach $17.75 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.0%. This expansion during the forecast period is attributed to the increasing adoption of precision neurology approaches, rising investments in digital diagnostics platforms, the broadening of personalized treatment planning, the growing utilization of tele-neurology services, and advancements in neuroinformatics and analytics. Major trends anticipated in this period include the increasing integration of AI-assisted neuroimaging tools, a rising application of biomarker-based diagnostic kits, the growing integration of genetic and molecular testing, an expansion of remote and digital cognitive assessments, and an enhanced focus on early disease detection._x000D_

_x000D_

#Access Your Free Sample Report for In-Depth Market Insights:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=19611&type=smp_x000D_

_x000D_

What Drivers Are Affecting Demand-Supply Dynamics In The Neurological Disorder Diagnostics Market?_x000D_

The rising occurrence of Alzheimer’s disease is anticipated to drive expansion in the neurological disorder diagnostics market in the future. Alzheimer’s disease is defined as a progressive neurodegenerative condition marked by a slow deterioration of cognitive abilities, such as memory, reasoning, and problem-solving skills. This condition results from a combination of elements like genetic factors, including specific gene mutations and variations; the buildup of amyloid plaques and tau tangles within the brain; persistent inflammation; vascular problems; and various lifestyle aspects. Diagnostic tools for neurological disorders assist in managing Alzheimer’s by facilitating its early and precise identification using sophisticated imaging methods, biomarker analysis, and cognitive evaluations. As an illustration, data from September 2024, provided by the Australian Institute of Health and Welfare, a government agency located in Australia, indicated that in 2023, roughly 411,100 people in Australia were affected by dementia, with approximately 257,500 being women and 153,700 men. Consequently, the growing incidence of Alzheimer’s disease is fueling the expansion of the neurological disorder diagnostics market._x000D_

_x000D_

What Segments Are Included Within The Neurological Disorder Diagnostics Market?_x000D_

The neurological disorder diagnostics market covered in this report is segmented –_x000D_

_x000D_

1) By Component: Instruments, Reagents, Kits, Software, Services_x000D_

2) By Technology: Immunoassay, Polymerase Chain Reaction (PCR) Techniques_x000D_

3) By Disease Type: Alzheimer’s Disease, Dementia, Parkinson’s Disease, Epilepsy, Traumatic Brain Injury, Other Disease Types_x000D_

4) By End User: Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes_x000D_

_x000D_

Subsegments:_x000D_

1) By Instruments: Electroencephalography (EEG) Machines, Magnetic Resonance Imaging (MRI) Machines, Computed Tomography (CT) Scanners, Positron Emission Tomography (PET) Scanners, Lumbar Puncture Equipment, Ultrasound Devices, Neurostimulation Devices, Transcranial Magnetic Stimulation (TMS) Devices,_x000D_

2) By Reagents: Biochemical Reagents, Antibodies, DNA Probes, RNA Probes, Enzyme-linked Immunosorbent Assay (ELISA) Reagents, Polymerase Chain Reaction (PCR) Reagents, Sample Collection Reagents_x000D_

3) By Kits: Diagnostic Test Kits, Genetic Testing Kits, Biomarker Detection Kits, Immunoassay Kits, Point-of-Care Testing Kits, Screening Kits for Neurological Disorders_x000D_

4) By Software: Diagnostic Software for Imaging Analysis, Data Management Software, Clinical Decision Support Software, Patient Management Software, Laboratory Information Management Systems (LIMS), Neuroinformatics Software, Telemedicine Software_x000D_

5) By Services: Diagnostic Testing Services, Consultation Services, Training and Support Services, Maintenance and Repair Services for Equipment, Telehealth Services, Data Analysis Services, Research and Development Services_x000D_

_x000D_

What Upcoming Trends Are Likely To Define The Future Path Of The Neurological Disorder Diagnostics Market?_x000D_

Leading firms within the neurological disorder diagnostics market are concentrating on creating novel solutions, including neurological disease quantification software, to cater to the one billion individuals globally impacted by neurological diseases. This software serves as an instrument for assessing and examining brain activity and the advancement of neurological conditions. An example occurred in January 2024, when Quibim, a biotechnology company headquartered in Spain, introduced the QP-Brain, an AI-driven software designed for early-stage neurological disease quantification. QP-Brain from Quibim represents sophisticated neuroimaging analysis software developed to measure changes in brain tissue associated with neurological conditions. Its distinctive capabilities encompass AI-powered automated segmentation and comprehensive volumetric analysis, providing accurate understanding of shifts in brain structure for both clinical and research purposes._x000D_

_x000D_

Who Are The Primary Competitors In The Global Neurological Disorder Diagnostics Market?_x000D_

Major companies operating in the neurological disorder diagnostics market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Amgen Inc., Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Otsuka Pharmaceutical Co. Ltd., Boston Scientific Corporation, Neurocrine Biosciences Inc., Neusoft Medical Systems Co.Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, Esaote S.p.A, Canon Medical Systems Corporation, NeuroPace Inc., Lifelines Neuro Company LLC, York Instruments Ltd., Advanced Brain Monitoring Inc., Neurometrix Inc., Croton Healthcare Private Limited, NeuroLogica Corporation_x000D_

_x000D_

#Access The Complete Report For Deeper Market Insights:#_x000D_

https://www.thebusinessresearchcompany.com/report/neurological-disorder-diagnostics-global-market-report_x000D_

_x000D_

Which Regions Are Poised For Strategic Growth In The Neurological Disorder Diagnostics Market?_x000D_

North America was the largest region in the neurological disorder diagnostics market in 2025. The regions covered in the neurological disorder diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request Your Customized Neurological Disorder Diagnostics Market Research Report for Competitive Advantage:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=19611&type=smp_x000D_

_x000D_

#Browse Through More Reports Similar to the Global Neurological Disorder Diagnostics Market 2026, By The Business Research Company#_x000D_

_x000D_

Neuroscience Antibodies And Assays Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/neuroscience-antibodies-and-assays-global-market-report_x000D_

_x000D_

Interventional Neurology Devices And Equipment Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/interventional-neurology-devices-and-equipment-global-market-report_x000D_

_x000D_